News

Seven Things to Know About ProPublica’s Investigation of the FDA’s Secret Gamble on Generic Drugs
ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These ...
Iowa board files charges against mail-order pharmacy cited by FDA and California board
The board has charged the Iowa-licensed compounding pharmacy FarmaKeio with violating provisions of the federal Food, Drug ...
A University of Utah doctor’s research led to a major HIV drug. He worries federal cuts will stop people from getting it.
The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...
STAT14h
FDA probes deaths of boys taking Sarepta Duchenne drug
Viking Therapeutics announced the start of Phase 3 studies involving its injectable, GLP-1/GIP-targeted obesity drug, called ...
STAT2d
Top drug regulator is retiring as FDA departures mount
WASHINGTON — Jacqueline Corrigan-Curay, the top drug regulator at the Food and Drug Administration, is retiring from the ...
KSL2d
FDA approves HIV drug based on University of Utah biochemist's findings
Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...
MPR12h
Riliprubart Designated Orphan Drug Status for Antibody-Mediated Rejection
Riliprubart is an immunoglobulin G4 humanized antibody that is designed to selectively inhibit activated C1s in the classical complement pathway of the innate immune system.